SCHEMBL31031247

SCHEMBL31031247

Cc1ccc(S(=O)(=O)O[C@H]2CCN(c3ccn4c(nc5ccc(C)cc54)c3Cl)C2)cc1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP2D6 P10635 2/20 0.42
CYP1A2 P05177 1/20 0.36
IKBKB O14920 1/20 0.36
SMPD3 Q9NY59 2/20 0.35
MAPT P10636 7/20 0.32
TDP1 Q9NUW8 1/20 0.32
KMT2A Q03164 4/20 0.32
TP53 P04637 4/20 0.32
MEN1 O00255 3/20 0.32
HRH4 Q9H3N8 1/20 0.32
HRH3 Q9Y5N1 1/20 0.32
HSD11B1 P28845 1/20 0.32
ALDH1A1 P00352 3/20 0.31
LMNA P02545 1/20 0.31
GAA P10253 1/20 0.31
POLB P06746 2/20 0.31
RAB9A P51151 2/20 0.31
MAPK1 P28482 2/20 0.31
KDM4E B2RXH2 2/20 0.31
HTT P42858 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31031237 0.93 CYP2D6 (0.38) CYP2D6CYP1A2IKBKBSMPD3MAPT
SCHEMBL31031239 0.81 CYP2D6 (0.44) CYP2D6CYP1A2IKBKBMAPTKMT2A
SCHEMBL18838768 0.74 CYP2D6 (0.40) CYP2D6CYP1A2IKBKBMAPTKMT2A
SCHEMBL1410648 0.71 CYP2D6 (0.45) CYP2D6CYP1A2KMT2AMEN1HSD11B1
SCHEMBL7964234 0.68 CYP2D6 (0.53) CYP2D6CYP1A2MAPTTDP1KMT2A
SCHEMBL8630790 0.68 CYP2D6 (0.53) CYP2D6CYP1A2MAPTTDP1KMT2A
SCHEMBL7966928 0.68 CYP2D6 (0.53) CYP2D6CYP1A2MAPTTDP1KMT2A
SCHEMBL2405904 0.67 CYP2D6 (0.52) CYP2D6CYP1A2SMPD3MAPTKMT2A
SCHEMBL2405905 0.67 CYP2D6 (0.52) CYP2D6CYP1A2SMPD3MAPTKMT2A
SCHEMBL15718847 0.66 CYP2D6 (0.46) CYP2D6CYP1A2MAPTSMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4658651-A1 NOVEL COMPOUNDS FOR TAU IMAGING Eli Lilly and Company (US) 2025-12-10 EP disclosed
WO-2024163546-A1 NOVEL COMPOUNDS FOR TAU IMAGING ELI LILLY AND COMPANY (US) 2024-08-08 WO disclosed